Seeking Alpha

Shares of Aveo Pharmaceutical (AVEO -48%) resume trading after being halted earlier in the day...

Shares of Aveo Pharmaceutical (AVEO -48%) resume trading after being halted earlier in the day following an FDA panel vote of 13 to 1 that its application for Tivozanib did not demonstrate a favorable benefit-to-risk evaluation for the treatment of advanced renal cell carcinoma.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|